PHMB 0.08%

DRUG2 trials

Sponsors

SIFI SpA

Conditions

Acanthamoeba Keratitis

Phase 3

Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis

CompletedNCT03274895

SIFI SpAAcanthamoeba Keratitis

Start: 2017-08-13End: 2022-03-30Updated: 2023-08-22

Unknown Phase

Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

CompletedNCT07195864

SIFI SpAAcanthamoeba Keratitis

Start: 2025-10-30End: 2026-06-11Updated: 2026-06-22

Related Papers

The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1.

2023-10-0530 citations